. Author manuscript; available in PMC: 2019 Oct 28.

Published in final edited form as: Pediatr Blood Cancer. 2017 Sep 14;65(1):10.1002/pbc.26776. doi: 10.1002/pbc.26776

TABLE 2.

Patient Characteristics, Post-Thiotepa Attributable Toxicities.

	Thiotepa Course 1 (58 patients)	Thiotepa Course 2 (38 patients)

Toxicity (Number of Patients)	CNS-general Gr. III (2) Hepatic Gr. III (1) Infection Gr. III (1) Respiratory Gr. V (1) Immunosuppression Gr. V (1)	Respiratory Gr. III (1) Gastrointestinal Gr. III (1) Neurological Gr. III (1)

Days of Hospitalization
Range	0–34 days	0–54 days
Median	6 days	4 days

Patients who were never hospitalized	13 patients (22.4%)	9 patients (23.7%)